Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retatrutide, also known as LY3437943, is an engineered 39-amino-acid peptide based on the GIP peptide backbone that can activate three receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR)
Additionally, Rybelsus suppresses glucagon secretion , slows gastric emptying, and promotes satiety, which can contribute to modest weight lossa beneficial effect for many individuals with type 2 diabetes, though it is important to note that Rybelsus is not licensed for weight loss in the UK
Potential mild issues include injection-site irritation or reactions related to copper sensitivity
By integrating these receptor activities, Retatrutide creates a synergistic effect that addresses interconnected metabolic challenges
